The existing Essure procedure does not immediately provide permanent birth control. It instead requires the patient to wait for a period of 90 days, during which time the body grows over the inserted ...

Conceptus (CPTS) announced that it has reached an agreement with Hologic (HOLX) to settle the ongoing patent infringement litigation related to Hologic's Adiana Permanent Contraception System. The ...

Conceptus (CPTS) delivered a positive first quarter earnings surprise of 30.8% on April 26, but shares of this birth control company have been on an upswing since January. Owing to an uptrend in ...

FRANKFURT, Germany (AP) -- German drug company Bayer AG says it has agreed to buy California-based Conceptus for around $1.1 billion to expand the kinds of birth control it offers. Bayer said Monday ...

BANGALORE (Reuters) - Contraception device maker Conceptus Inc , which was sitting on a potential billion dollar women's sterilization market, now faces a growing threat from the entry of Hologic ...

Adds Essure®, the only non-surgical permanent birth control method, to Bayer's contraception portfolio Leverkusen, Germany / Mountain View, Calif. (U.S.A.), April 29, 2013 – Bayer intends to broaden ...

Frankfurt-based Bayer to pay %2431 a share for California-based Conceptus Conceptus makes irreversible birth control method Essure is coil-based product that blocks a woman%27s fallopian tubes ...

MOUNTAIN VIEW, Calif., May 2, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure ® procedure, the most effective permanent birth control method available, today introduced ...

Germany's Bayer AG has agreed to buy U.S. contraceptive devices maker Conceptus for $1.1 billion, aiming to underpin its position as the world's largest women's healthcare provider. Bayer, whose ...

Bayer announced that it has signed a merger agreement with US-based birth-control specialist Conceptus. Bayer announced that it has signed a merger agreement with US-based birth-control specialist ...

Contraception device maker Conceptus Inc. ( CPTS) reported earnings per share (EPS) of 7 cents during the third quarter of fiscal 2012, compared to net loss of 9 cents per share in the year-ago ...

Bayer said the deal would enable it to offer a complete range of contraceptive products for women German healthcare firm Bayer plans to buy US contraceptive maker Conceptus in a $1.1bn (£700m) deal to ...